Health Care Select Sector SPDR Fund(XLV),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

XLV Health Care Select Sector SPDR Fund

Trading 12-17 15:28:24 EST

153.79

-0.28

-0.18%

High154.77	Low153.67	Vol7.01M
Open154.23	D1 Closing154.07	Amplitude0.71%
Mkt Cap40.11B	Tradable Cap40.11B	Total Shares260.82M
T/O1.08B	T/O Rate2.69%	Tradable Shares260.82M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"XLV","market":"US","secType":"STK","nameCN":"Health Care Select Sector SPDR Fund","latestPrice":153.785,"timestamp":1766003304408,"preClose":154.07,"halted":0,"volume":7006181,"delay":0,"floatShares":260815324,"shares":260815324,"eps":-14.217021,"marketStatus":"Trading","change":-0.285,"latestTime":"12-17 15:28:24 EST","open":154.23,"high":154.77,"low":153.67,"amount":1080748749.24107,"amplitude":0.00714,"askPrice":153.79,"askSize":175,"bidPrice":153.78,"bidSize":430,"shortable":3,"etf":1,"ttmEps":-14.217021,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1766005200000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":154.07,"sharesOutstanding":260815324,"nav":156.084998,"aum":40709359214.17,"dividendRate":0.0159,"bidAskSpread":0.000064,"preHourTrading":{"tag":"盘前","latestPrice":154.23,"preClose":154.07,"latestTime":"09:28 EST","volume":2985,"amount":460293.41774999996,"timestamp":1765981735597},"postHourTrading":{"tag":"盘后","latestPrice":153.7,"preClose":154.07,"latestTime":"19:54 EST","volume":60997,"amount":9397566.0695,"timestamp":1765932859589},"volumeRatio":0.539129,"impliedVol":0.155,"impliedVolPercentile":0.292},"requestUrl":"/m/hq/s/XLV/tweets","defaultTab":"tweets","newsList":[{"id":"2592910151","title":"Alignment Healthcare Is Maintained at Overweight by JP Morgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2592910151","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592910151?lang=en_us&edition=fundamental","pubTime":"2025-12-18 03:29","pubTimestamp":1765999740,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ALHC/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 17, 2025 14:29 ET (19:29 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALHC","XLV"],"gpt_icon":0},{"id":"2592910836","title":"Sector Update: Health Care Stocks Softer Wednesday Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2592910836","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592910836?lang=en_us&edition=fundamental","pubTime":"2025-12-18 02:59","pubTimestamp":1765997946,"startTime":"0","endTime":"0","summary":"Health care stocks were lower Wednesday afternoon, with the NYSE Health Care Index and the State Street Health Care Select Sector SPDR ETF  each decreasing 0.2%.The iShares Biotechnology ETF  eased 0.1%.In corporate news, Vistagen Therapeutics  shares tumbled 80% after Maxim downgraded the company to hold from buy.The White House is set to announce deals with Novartis  and Roche on drug pricing, Bloomberg reported Wednesday. Other drugmakers may be included in the announcement, the report said. Novartis shares rose 0.4%.Medline  shares surged 30% in their trading debut on Nasdaq Wednesday after the company priced an upsized IPO of about 216 million class A shares at $29 per share.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE0002141913.USD","IE00B2B36J28.USD","BK4581","BK4578","LABU","LU0211331839.USD","VTGN","BK4532","IE00BJT1NW94.SGD","LU0208291251.USD","BK4007","IE00B4R5TH58.HKD","LU0070302665.USD","LU0320765489.SGD","NVS","IE00BJJMRZ35.SGD","IE0009355771.USD","IE00BFTCPJ56.SGD","BK4588","XBI","IBB","BK4585","BK4139","XLV"],"gpt_icon":1},{"id":"2592913296","title":"Exchange-Traded Funds, Equity Futures Higher Pre-Bell Wednesday as Investors Digest Latest Economic Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2592913296","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592913296?lang=en_us&edition=fundamental","pubTime":"2025-12-17 22:05","pubTimestamp":1765980322,"startTime":"0","endTime":"0","summary":"The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.4% and the actively traded Invesco QQQ Trust (QQQ) was 0.5% higher in Wednesday's premarket activity as investors digest the","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["FAS","USO","ZIM.AU","IYH","BETH","QQQ","UNG","XLY","XLV","IYK","RTH","XLI","XRT","XLP","XSD","JBL","EETH","VIS","SOXX","IGM","EQR","EEM","BITO","VHT","VHT.AU","TTE","LEN","XLK","RTH.AU","IVV","IPK","IYJ","IYE","ZIM",".IXIC","XLE","XLF","FAZ","SPY","IYW","ALVO","IBB","SPY.AU","LEN/WD","PMR","VDC","ISBC"],"gpt_icon":1},{"id":"2592983911","title":"Assessing Diversified Healthcare Trust (DHC)’s Valuation as Its 2025 Portfolio and Balance Sheet Plan Takes Shape","url":"https://stock-news.laohu8.com/highlight/detail?id=2592983911","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592983911?lang=en_us&edition=fundamental","pubTime":"2025-12-17 21:22","pubTimestamp":1765977765,"startTime":"0","endTime":"0","summary":"Diversified Healthcare Trust (DHC) just laid out a 2025 game plan centered on selling non core properties, targeting $625 million to $635 million in proceeds to chip away at debt and recycle capital.\nSee our latest analysis for Diversified Healthcare Trust.\nThat renewed focus on pruning non core assets comes after a big recovery in sentiment, with the share price now at $4.82 and a year to date share price return of 112.33%, while the three year total shareholder return of 692.17% shows how...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9621071-choice1-main-header/1585186852842","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9621071-choice1-main-header/1585186852842"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/real-estate/nasdaq-dhc/diversified-healthcare-trust/news/assessing-diversified-healthcare-trust-dhcs-valuation-as-its","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/real-estate/nasdaq-dhc/diversified-healthcare-trust/news/assessing-diversified-healthcare-trust-dhcs-valuation-as-its","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DHC","LABU","XLV","BK4203","BK4588","DCF","BK4225","BK4585","BK4581","XBI"],"gpt_icon":0},{"id":"2592996911","title":"Prestige Consumer Healthcare (PBH): Revisiting Valuation After Brandes Stake, Buybacks and 2026 Revenue Guidance Reaffirmation","url":"https://stock-news.laohu8.com/highlight/detail?id=2592996911","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592996911?lang=en_us&edition=fundamental","pubTime":"2025-12-17 21:16","pubTimestamp":1765977391,"startTime":"0","endTime":"0","summary":"Brandes Small Cap Value Fund’s new stake in Prestige Consumer Healthcare (PBH), together with the company’s sizable buybacks and steady 2026 revenue guidance, has put fresh attention on this quietly evolving OTC portfolio story.\nSee our latest analysis for Prestige Consumer Healthcare.\nDespite the new institutional interest, the short term picture is still cautious, with a negative year to date share price return alongside a weaker 1 year total shareholder return, even though the 5 year total...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-pbh/prestige-consumer-healthcare/news/prestige-consumer-healthcare-pbh-revisiting-valuation-after","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-pbh/prestige-consumer-healthcare/news/prestige-consumer-healthcare-pbh-revisiting-valuation-after","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["XLV","HCSG","PBH.AU","PBH"],"gpt_icon":0},{"id":"2592642918","title":"Septerna to Present at 44th Annual J.P. Morgan Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2592642918","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592642918?lang=en_us&edition=fundamental","pubTime":"2025-12-17 21:00","pubTimestamp":1765976400,"startTime":"0","endTime":"0","summary":"SOUTH SAN FRANCISCO, Calif., Dec.  17, 2025   -- Septerna, Inc. , a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor  drug discovery, today announced that Jeffrey Finer, M.D., Ph.D., chief executive officer and co-founder of Septerna, will present at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, at 3:45 p.m. PT in San Francisco. A live webcast of the presentation will be available in the investors section of the company’s website at www.septerna.com. The webcast will be archived for at least 30 days following the presentation. About SepternaSepterna, Inc. is a clinical-stage biotechnology company with a world-class team of GPCR experts and drug developers advancing cutting-edge science to unlock the full potential of GPCR therapies for patients with significant unmet needs. The company’s proprietary Native Complex Platform is designed to enable new approaches to GPCR drug discovery and has led to the development o","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/17/3206946/0/en/Septerna-to-Present-at-44th-Annual-J-P-Morgan-Healthcare-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4504","GPCR","LU0320765646.SGD","LU1791710582.SGD","LU2111349929.HKD","LU0158827781.USD","LU0128526141.USD","LU1244550577.SGD","LU1244550221.USD","LU2357305700.SGD","LU0882574139.USD","LU1074936037.SGD","HCSG","LU2089283258.USD","LU0106831901.USD","LU0234570918.USD","LU2133065610.SGD","LU1791710400.SGD","BK4588","LU1162221912.USD","BK4516","LU0106261372.USD","LU0029874061.USD","LU0267386448.USD","LU1668664300.SGD","BK4534","BK4599","LU2023251221.USD","LU2347655156.SGD","LU2089284900.SGD","LABU","LU1720051017.SGD","BK4581","LU0795875086.SGD","XLV","XBI","LU2028103732.USD","LU1244550494.USD","LU0158827948.USD","LU2271345857.HKD","LU0971096721.USD","LU0528227936.USD","LU0225283273.USD","BK4127","BK4585","SEPN","LU1720051108.HKD","LU1548497426.USD","LU0314104364.USD","LU0912757837.SGD"],"gpt_icon":0},{"id":"2592979089","title":"Compass Therapeutics to Participate in the J.P. Morgan 2026 Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2592979089","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592979089?lang=en_us&edition=fundamental","pubTime":"2025-12-17 20:30","pubTimestamp":1765974600,"startTime":"0","endTime":"0","summary":"BOSTON, Dec.  17, 2025  (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics, ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/17/3206900/0/en/Compass-Therapeutics-to-Participate-in-the-J-P-Morgan-2026-Healthcare-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1074936037.SGD","HCSG","LU0882574139.USD","BK4137","BK4585","IE00BZ1G4Q59.USD","LU1791710582.SGD","LU2089283258.USD","XBI","LU2028103732.USD","LU1244550577.SGD","LU0795875169.SGD","LU0528227936.USD","LABU","LU1668664300.SGD","CMPX","BK4534","BK4516","LU0006306889.USD","LU0314104364.USD","LU0320765646.SGD","LU0267386448.USD","LU0128526141.USD","LU2271345857.HKD","LU0971096721.USD","LU2023251221.USD","LU0098860793.USD","LU2089284900.SGD","XLV","BK4588","LU0158827781.USD","LU0106261372.USD","LU0795875086.SGD","LU1244550494.USD","LU2133065610.SGD","LU1162221912.USD","BK4581","IE00BKVL7J92.USD","LU2111349929.HKD","LU1720051017.SGD","LU1791710400.SGD","BK4139","LU2347655156.SGD","LU1732799900.SGD","LU0106831901.USD","BK4504","LU1548497426.USD","LU1720051108.HKD","LU0225283273.USD","LU1732800096.USD"],"gpt_icon":0},{"id":"2592959924","title":"Benign Growth For Yestar Healthcare Holdings Company Limited (HKG:2393) Underpins Its Share Price","url":"https://stock-news.laohu8.com/highlight/detail?id=2592959924","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592959924?lang=en_us&edition=fundamental","pubTime":"2025-12-17 06:02","pubTimestamp":1765922551,"startTime":"0","endTime":"0","summary":"Yestar Healthcare Holdings Company Limited's ( HKG:2393 ) price-to-sales (or \"P/S\") ratio of 0.1x might make it look...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6022000-choice1-main-header/1585186795401","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6022000-choice1-main-header/1585186795401"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/healthcare/hkg-2393/yestar-healthcare-holdings-shares/news/benign-growth-for-yestar-healthcare-holdings-company-limited","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/healthcare/hkg-2393/yestar-healthcare-holdings-shares/news/benign-growth-for-yestar-healthcare-holdings-company-limited","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["XBI","BK4581","BK4585","XLV","LU0128526141.USD","BK4588","LABU","02393","BK1222","HCSG","BK4137","LU0029874061.USD"],"gpt_icon":0},{"id":"2592309189","title":"Molina Healthcare Inc. Stock Sheds 3.4%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2592309189","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592309189?lang=en_us&edition=fundamental","pubTime":"2025-12-17 05:35","pubTimestamp":1765920900,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Molina Healthcare Inc. slipped 3.4% to $160.88 on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.2% to 6,800.26 and Dow Jones Industrial Average falling 0.6% to 48,114.26.This was the stock's second consecutive day of losses.Molina Healthcare Inc. closed 55.3% short of its 52-week high of $359.97, which the company reached on April 4th.Despite its losses, the stock outperformed some of its peers, as Humana Inc. fell 6.0% to $258.16, Centene Corp. fell 3.7% to $38.97.Trading volume totaled 1.2 million, compared to the 50-day average of 1.8 million.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MOH","XLV"],"gpt_icon":0},{"id":"2592930331","title":"Clover Health to Participate in Upcoming J.P. Morgan 2026 Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2592930331","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592930331?lang=en_us&edition=fundamental","pubTime":"2025-12-17 05:05","pubTimestamp":1765919100,"startTime":"0","endTime":"0","summary":"WILMINGTON, Del., Dec.  16, 2025  (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Executive Officer, An","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/16/3206609/0/en/Clover-Health-to-Participate-in-Upcoming-J-P-Morgan-2026-Healthcare-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","LU0158827781.USD","LU0795875169.SGD","LU0158827948.USD","XBI","LU0557290698.USD","LU2089283258.USD","LABU","LU0225283273.USD","LU0912757837.SGD","LU2023251221.USD","LU0029874061.USD","BK4534","LU1720051108.HKD","LU2111349929.HKD","BK4516","LU1244550221.USD","LU0106261372.USD","LU1668664300.SGD","LU0006306889.USD","LU2028103732.USD","IE00BZ1G4Q59.USD","LU1244550494.USD","LU0098860793.USD","LU1732800096.USD","LU2347655156.SGD","XLV","LU0106831901.USD","LU0267386448.USD","LU1162221912.USD","LU1548497426.USD","IE00BKVL7J92.USD","LU1791710582.SGD","LU2133065610.SGD","LU0795875086.SGD","LU1720051017.SGD","BK4137","BK4588","LU0234570918.USD","LU1791710400.SGD","HCSG","LU1989772840.SGD","LU0882574139.USD","BK4127","LU1363072403.SGD","LU0128526141.USD","LU2271345857.HKD","LU1989772923.USD","LU0320765646.SGD","LU2089284900.SGD"],"gpt_icon":0},{"id":"2592493247","title":"Mark Cuban Says Healthcare Is Broken When Doctors Can't Take Wednesdays Off To Golf. A Healthy System Used To Make That Possible","url":"https://stock-news.laohu8.com/highlight/detail?id=2592493247","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592493247?lang=en_us&edition=fundamental","pubTime":"2025-12-17 04:31","pubTimestamp":1765917060,"startTime":"0","endTime":"0","summary":"Mark Cuban has been speaking out loudly about what he sees as serious flaws in the U.S. healthcare system. In his view, the system is so bloated with complexity and middlemen that it distracts doctors from what they actually signed up to do: care for patients.Instead, Cuban says the U.S. healthcare system has become a tangled web. “Every complication you add is an opportunity for arbitrage,” he said, criticizing the layers of complexity that allow third parties to profit while driving up costs for patients and burying doctors in paperwork.Doctors, he said, are caught in the middle. “Let me just tell you upfront, doctors are underpaid,” Cuban said on the podcast, especially when comparing their pay to what hospitals actually bill for major procedures. “I want that motherf***er doctor to make $10,000,” he said about heart surgeons, arguing they should be focused on saving lives, not scrambling to cover bills.Cuban also reflected on what he sees as the root of the problem: insurance compa","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/12/16/Cuban-Critiques-Plans.jpeg?optimize=medium&dpr=2&auto=webp&width=120","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/12/16/Cuban-Critiques-Plans.jpeg?optimize=medium&dpr=2&auto=webp&width=120"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/topics/25/12/49433709/mark-cuban-says-healthcare-is-broken-when-doctors-cant-take-wednesdays-off-to-golf-a-healthy-system-used-to-make-that-possible","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/topics/25/12/49433709/mark-cuban-says-healthcare-is-broken-when-doctors-cant-take-wednesdays-off-to-golf-a-healthy-system-used-to-make-that-possible","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["XBI","BK4581","BK4585","XLV","LU0128526141.USD","BK4588","LABU","HCSG","BK4137","LU0029874061.USD"],"gpt_icon":0},{"id":"2592293104","title":"Sector Update: Health Care Stocks Retreat Tuesday Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2592293104","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592293104?lang=en_us&edition=fundamental","pubTime":"2025-12-17 02:46","pubTimestamp":1765910802,"startTime":"0","endTime":"0","summary":"Health care stocks declined Tuesday afternoon, with the NYSE Health Care Index falling 1.7% and the State Street Health Care Select Sector SPDR ETF  dropping 1.9%.The iShares Biotechnology ETF  retreated 1.1%.In corporate news, Pfizer  issued an earnings outlook for 2026 below market expectations and said its COVID-19 sales are expected to decline during the year on an annual basis, while the pharmaceutical giant revised its revenue guidance for 2025. Its shares dropped 5.1%.Abivax  stock fell 5.8% after the company reported a wider Q3 loss.Medtronic  shares fell 1.2% after Baird cut the company's price target to $103 from $109, and kept its neutral rating.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0432979614.USD","LU2112291526.USD","BK4082","LU1057294990.SGD","LU0211326755.USD","IE00BBT3K403.USD","IE00B19Z3581.USD","SG9999002232.USD","BK4599","SG9999013999.USD","LU0496365809.HKD","LU1894683348.USD","SG9999003800.SGD","LU1883839398.USD","LU0456855351.SGD","LU1116320901.HKD","BK4534","LU1066053197.SGD","LU1244550221.USD","LABU","LU1989771016.USD","LU0211331839.USD","LU0058720904.USD","LU0306807586.USD","LU0265550359.USD","LU0976567544.SGD","IE00B3PB1722.GBP","LU1023059063.AUD","BK4568","LU2023251221.USD","IE00BGHQF631.EUR","IE00BLSP4452.SGD","LU1989764664.SGD","XBI","BK4585","SG9999011175.SGD","LU2089283258.USD","LU0265550946.USD","IBB","LU1066051498.USD","LU0321505439.SGD","LU0158827781.USD","PFE","LU0321505868.SGD","IE00BLSP4239.USD","BK4581","LU0985481810.HKD","IE0002270589.USD","SG9999001176.SGD","LU2271345857.HKD","IE00BQXX3F31.USD","LU0070302665.USD","XLV","LU0072461881.USD","LU2028103732.USD","SGXZ57979304.SGD","LU0306806265.USD","BK4550","BK4592","LU1244550577.SGD","LU1894683264.USD","BK7095","LU1116320737.USD","LU0314106906.USD","LU2089284900.SGD","LU2089984988.USD","SG9999002224.SGD","IE00BVYPNV92.GBP","LU0868494617.USD","BK4007","SG9999001176.USD","BK4533","LU0170899867.USD","IE00B3T34201.USD","LU0225771236.USD","IE000M9KFDE8.USD","IE00BFXG1179.USD","BK4139","IE00BQXX3D17.EUR","LU2111349929.HKD","LU1571399168.USD","LU0211326839.USD","IE00BDGV0183.EUR","BK4566","BK4588","LU0320765489.SGD","LU1506573853.SGD","LU0162691827.USD","LU0208291251.USD","LU0234572021.USD","LU1061106388.HKD","LU0289739699.SGD","LU1291159041.SGD","IE00BQXX3C00.GBP","LU0122379950.USD","LU0225284248.USD","LU1983299246.USD","LU1244550494.USD","IE00B42XCP33.USD","LU2468319806.SGD","IE00B19Z3B42.SGD","IE00BVYPNW00.USD","LU0158827948.USD","LU1989764748.USD"],"gpt_icon":1},{"id":"2592953759","title":"Should Ryman’s $1b Recap and Australian Funding Shift Require Action From Ryman Healthcare (NZSE:RYM) Investors?","url":"https://stock-news.laohu8.com/highlight/detail?id=2592953759","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592953759?lang=en_us&edition=fundamental","pubTime":"2025-12-16 23:17","pubTimestamp":1765898245,"startTime":"0","endTime":"0","summary":"Ryman Healthcare has recently completed a financial overhaul under new CEO Naomi James, including a very large capital raising of about $1.00 billion and a reset of its capital structure, while Australian aged-care reforms have improved funding arrangements for operators.\nA key shift is that Australian rules now allow providers like Ryman to retain a portion of new refundable accommodation deposits, creating a structurally more supportive revenue model for its care operations.\nWe’ll now...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6033000-choice2-main-header/1585186569462","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6033000-choice2-main-header/1585186569462"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/nz/healthcare/nzx-rym/ryman-healthcare-shares/news/should-rymans-1b-recap-and-australian-funding-shift-require","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/nz/healthcare/nzx-rym/ryman-healthcare-shares/news/should-rymans-1b-recap-and-australian-funding-shift-require","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["XAO.AU","BK4211","RYM","XJO.AU","BK8050","XKO.AU","ISBC","XLV","BK4585","LABU","RYM.NZ","XBI","BK4588","BK4152","BK4581"],"gpt_icon":0},{"id":"2591933150","title":"Jefferies Adjusts Molina Healthcare Price Target to $160 From $162, Maintains Hold Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2591933150","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591933150?lang=en_us&edition=fundamental","pubTime":"2025-12-16 23:13","pubTimestamp":1765898028,"startTime":"0","endTime":"0","summary":"Molina Healthcare (MOH) has an average rating of Hold and mean price target of $172.81, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XLV","MOH"],"gpt_icon":0},{"id":"1107866208","title":"BofA Survey: Healthcare Tops European Fund Managers' Overweight Sectors","url":"https://stock-news.laohu8.com/highlight/detail?id=1107866208","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107866208?lang=en_us&edition=fundamental","pubTime":"2025-12-16 23:12","pubTimestamp":1765897931,"startTime":"0","endTime":"0","summary":"According to Bank of America's December survey of European fund managers, healthcare remains the most overweight sector among European portfolio managers. However, financials continue to be a favored...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","XBI","BK4588","BK4585","LABU","159760","BK4581"],"gpt_icon":0},{"id":"2591989714","title":"Healthcare is Largest Sector Overweight for European Fund Managers in BofA Survey -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2591989714","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591989714?lang=en_us&edition=fundamental","pubTime":"2025-12-16 20:04","pubTimestamp":1765886640,"startTime":"0","endTime":"0","summary":"Copyright (c) 2025 Dow Jones & Company, Inc.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HCSG","XLV"],"gpt_icon":0},{"id":"2591981666","title":"Lifecore Biomedical to Participate at 44th Annual J.P. Morgan Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2591981666","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591981666?lang=en_us&edition=fundamental","pubTime":"2025-12-16 20:00","pubTimestamp":1765886400,"startTime":"0","endTime":"0","summary":"CHASKA, Minn., Dec.  16, 2025   -- Lifecore Biomedical, Inc.  , a fully integrated contract development and manufacturing organization , today announced that the company will participate at the 44th Annual J.P. Morgan Healthcare Conference. The conference will take place January 12-15, 2026, in San Francisco, California. Details regarding Lifecore’s participation are as follows: 44th Annual J.P. Morgan Healthcare ConferenceDetails: Lifecore management, including Paul Josephs, chief executive officer, and Ryan Lake, chief financial officer, will participate in 1-on-1 meetings Conference Dates: January 12-15, 2026Location: San Francisco, California About Lifecore Biomedical Lifecore Biomedical, Inc.  is a fully integrated contract development and manufacturing organization  that offers highly differentiated capabilities in the development, fill and finish of sterile injectable pharmaceutical products in syringes, vials, and cartridges, including complex formulations. As a leading manufac","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/16/3206095/23089/en/Lifecore-Biomedical-to-Participate-at-44th-Annual-J-P-Morgan-Healthcare-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0098860793.USD","BK4139","BK4121","LU1363072403.SGD","LU1668664300.SGD","IE00BKVL7J92.USD","LU1720051017.SGD","LU2111349929.HKD","CFO","LABU","LU0106261372.USD","BK4588","LU0106831901.USD","LU0128526141.USD","BK4534","LU0971096721.USD","LU1244550221.USD","LU0557290698.USD","LU0158827781.USD","LU1989772840.SGD","LU2028103732.USD","XLV","LU1720051108.HKD","LU0314104364.USD","XBI","LU0029874061.USD","LU1989772923.USD","LU2271345857.HKD","BK4137","LU1162221912.USD","LU0912757837.SGD","LU1791710400.SGD","HCSG","IE00BZ1G4Q59.USD","LU1732800096.USD","LU2089283258.USD","LU0528227936.USD","LU0234570918.USD","LU0006306889.USD","LU0158827948.USD","LU0225283273.USD","BK4585","LFCR","LU0795875169.SGD","LU2089284900.SGD","LU0795875086.SGD","LU2347655156.SGD","CDMO","BK4504","BK4581"],"gpt_icon":0},{"id":"2591600991","title":"China Healthcare Sector's Out-Licensing Set to Stay Strong -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2591600991","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591600991?lang=en_us&edition=fundamental","pubTime":"2025-12-16 17:31","pubTimestamp":1765877460,"startTime":"0","endTime":"0","summary":"0931 GMT - Innovation in China's healthcare sector should remain a key theme for 2026 despite recent underperformance, which Nomura analyst Jialin Zhang attributes to profit-taking. Zhang expects out-licensing activity to stay strong, supported by continued research and development investment, sustained cost and efficiency advantages over overseas peers, and fewer geopolitical hurdles following the recent U.S.-China trade truce. Zhang says it is critical to monitor the clinical progress of out-licensed assets next year, including data readouts and the speed of clinical trials. RNAi-based therapies could drive the next wave of out-licensing after weight-loss and oncology treatments, he adds, with IPO filings from RNAi companies potentially drawing further investor interest to the segment. Nomura tips Hengrui, Innovent, BeOne Medicines, Wuxi XDC and Mindray as its sector picks. ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","LU0128526141.USD","XBI","XLV","BK4581","HCSG","BK4137","BK4585","LU0029874061.USD","BK4588"],"gpt_icon":0},{"id":"2591606169","title":"Yestar Healthcare Explores Expansion Into Advanced Materials; Shares Fall 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591606169","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591606169?lang=en_us&edition=fundamental","pubTime":"2025-12-16 15:07","pubTimestamp":1765868844,"startTime":"0","endTime":"0","summary":"Yestar Healthcare  said it is exploring a potential expansion into the advanced materials industry, according to a Monday Hong Kong bourse filing.Shares of the healthcare consumables and equipment maker were down nearly 5% in Tuesday afternoon trading.The company said it is assessing potential investments in coating production lines, research and development equipment, and related patents, with an initial focus on applications in the oil and gas, hydrogen, and new energy sectors.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02393","BK4157","LU0128526141.USD","LU1815336091.USD","IE00B66KJ199.SGD","BK4585","IE00B19Z4B17.USD","BK4581","IE0031619046.USD","XLV","AEIS","LU0757428866.USD","LU0029874061.USD","IE00B7SZL793.SGD","BK4137","LABU","BK4588","BK1222","HCSG","XBI"],"gpt_icon":0},{"id":"2591160659","title":"Hygeia Healthcare's Share Buyback Could Boost Sentiment -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2591160659","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591160659?lang=en_us&edition=fundamental","pubTime":"2025-12-16 14:59","pubTimestamp":1765868340,"startTime":"0","endTime":"0","summary":"0659 GMT - Hygeia Healthcare's share buyback program of at least 300 million yuan reflects management's view that the stock is undervalued, which could improve investor sentiment, Citi Research analysts say in a note. Hygeia is funding the buyback with internal cash flow, reinforcing its shift to a more cash-generative business model without straining its improving financial position, Citi says. The buyback could provide technical support and a visible demand floor for the shares in the open market over the near term, Citi adds. The combination of direct buying and improved market perception could drive the stock higher over the next 90 days. Shares last traded at HK$12.11. ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK4137","LU0128526141.USD","LABU","06078","LU2488822045.USD","XLV","BK4581","LU0329678337.USD","BK4585","LU0029874061.USD","LU0329678170.USD","LU0737861772.HKD","XBI","HCSG","BK1209","BK4588"],"gpt_icon":0}],"profile":{"websiteUrl":"http://us.spdrs.com/etf/health-care-select-sector-spdr-fund-XLV","stockEarnings":[{"period":"1week","weight":0.0274},{"period":"1month","weight":0.0148},{"period":"3month","weight":0.123},{"period":"6month","weight":0.1563},{"period":"1year","weight":0.106},{"period":"ytd","weight":0.1199}],"compareEarnings":[{"period":"1week","weight":-0.0061},{"period":"1month","weight":0.0103},{"period":"3month","weight":0.0299},{"period":"6month","weight":0.1363},{"period":"1year","weight":0.1188},{"period":"ytd","weight":0.1583}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.","yearOnYearQuotes":[{"month":1,"riseRate":0.62963,"avgChangeRate":0.009894},{"month":2,"riseRate":0.555556,"avgChangeRate":-0.003401},{"month":3,"riseRate":0.592593,"avgChangeRate":0.009157},{"month":4,"riseRate":0.555556,"avgChangeRate":0.01362},{"month":5,"riseRate":0.666667,"avgChangeRate":0.004476},{"month":6,"riseRate":0.518519,"avgChangeRate":0.002804},{"month":7,"riseRate":0.62963,"avgChangeRate":0.011509},{"month":8,"riseRate":0.555556,"avgChangeRate":0.001611},{"month":9,"riseRate":0.37037,"avgChangeRate":-0.015959},{"month":10,"riseRate":0.592593,"avgChangeRate":0.007405},{"month":11,"riseRate":0.777778,"avgChangeRate":0.02456},{"month":12,"riseRate":0.666667,"avgChangeRate":0.01041}],"exchange":"ARCA","name":"Health Care Select Sector SPDR Fund","nameEN":"Health Care Select Sector SPDR Fund"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Health Care Select Sector SPDR Fund(XLV),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Health Care Select Sector SPDR Fund(XLV) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Health Care Select Sector SPDR Fund,XLV,Health Care Select Sector SPDR Fund股票,Health Care Select Sector SPDR Fund股票老虎,Health Care Select Sector SPDR Fund股票老虎国际,Health Care Select Sector SPDR Fund行情,Health Care Select Sector SPDR Fund股票行情,Health Care Select Sector SPDR Fund股价,Health Care Select Sector SPDR Fund股市,Health Care Select Sector SPDR Fund股票价格,Health Care Select Sector SPDR Fund股票交易,Health Care Select Sector SPDR Fund股票购买,Health Care Select Sector SPDR Fund股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Health Care Select Sector SPDR Fund(XLV),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Health Care Select Sector SPDR Fund(XLV) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}